Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Dayanidhi B. Behera
Observed names:
D Behera,
D. Behera,,
D.B. Behera,
Dayanidhi Behera
Institutions:
Narsee Monjee Institute of Management Studies,
Shri Vile Parle Kelavani Mandal
Observed institutions:
Odisha University of Agriculture and Technology,
Narsee Monjee Institute of Management Studies,
Glenmark Pharmaceuticals (India),
Shri Vile Parle Kelavani Mandal
ORCID:
0000-0002-8780-0937
Observed ORCID:
0000-0002-8780-0937
OpenAlex ID:
A5005537074
Effect of commonly used organic solvents on Aldehyde oxidase-mediated Vanillin, Phthalazine and Methotrexate oxidation in human, rat and mouse liver subcellular fractions
2014
·
Dayanidhi Behera
, Rambabu Pattem
, et al.
·
Xenobiotica
·
17
Performance evaluation of a low-cost manual sunflower thresher
2009
·
Anjana Goel
, Dayanidhi Behera
, et al.
·
Indian Journal of Agricultural Research
·
17
Design, synthesis and pharmacological evaluation of novel polycyclic heteroarene ethers as PDE10A inhibitors: Part I
2014
·
Sanjib Das
, Rajendra L. Harde
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
15
Preparation and characterization of rodent intestinal microsomes: Comparative assessment of two methods
2009
·
Anagha Damre
, SR Mallurwar
, et al.
·
Indian Journal of Pharmaceutical Sciences
·
12
PDF
In Vitro Evaluation of Hepatic and Extra-hepatic Metabolism of Coumarins Using Rat Subcellular Fractions: Correlation of In Vitro Clearance with In Vivo Data
2008
·
D. Behera,
, A. Damre,
, et al.
·
Drug metabolism and drug interactions
·
10
Tricyclic 4,4-dimethyl-3,4-dihydrochromeno[3,4-d]imidazole derivatives as microsomal prostaglandin E2 synthase-1 (mPGES-1) inhibitors: SAR and in vivo efficacy in hyperalgesia pain model
2017
·
Nagarajan Muthukaman
, Macchindra Tambe
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
9
Development of potent and selective Cathepsin C inhibitors free of aortic binding liability by application of a conformational restriction strategy
2021
·
Abhisek Banerjee
, Ranganadh Velagaleti
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
8
Discovery of furan and dihydrofuran-fused tricyclic benzo[d]imidazole derivatives as potent and orally efficacious microsomal prostaglandin E synthase-1 (mPGES-1) inhibitors: Part-1
2017
·
Nagarajan Muthukaman
, Macchindra Tambe
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
8
Fluorescent Probe Based Cyp Inhibition Assay: a High Throughput Tool for Early Drug Discovery Screening
2013
·
Sneha Nayadu
, Dayanidhi Behera
, et al.
·
7
Alleviating CYP and hERG liabilities by structure optimization of dihydrofuran-fused tricyclic benzo[d]imidazole series – Potent, selective and orally efficacious microsomal prostaglandin E synthase-1 (mPGES-1) inhibitors: Part-2
2018
·
Nagarajan Muthukaman
, Sanjay Deshmukh
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
6
An inhibitor of RORγ for chronic pulmonary obstructive disease treatment
2022
·
Harshada Desai
, Megha Marathe
, et al.
·
Scientific Reports
·
5
PDF
Utility of a column-switching LC/MS/MS method in cytochrome P450 inhibition assays using human liver microsomes
2013
·
Dayanidhi Behera
, Rambabu Pattem
, et al.
·
Drug metabolism and drug interactions
·
5
Beneficial Effects of Antioxidants on Oxidative Stress and Diabetes-Induced Experimental Nephropathy
2009
·
Taruna Katyal
, Manish Sharma
, et al.
·
5
A Short Review and Update on Epidemiology, Treatment, and Management of Herpes Zoster (Shingles) Infection
2026
·
Dayanidhi Behera
, Sateesh Belemkar
·
Current Pharmaceutical Design
·
3
Abstract 463: GRC 54276, a novel small molecule inhibitor of HPK1 has entered phase 1/2 clinical trial insolid malignancies and Hodgkin’s/non Hodgkin’s lymphoma
2023
·
Sravan Mandadi
, Sanjib Das
, et al.
·
Cancer Research
·
3
Abstract 462: A novel and potent Cblb inhibitor demonstrates robust immunological profile and anti-tumor efficacy
2023
·
Murugan Chinnapattu
, Sandeep Shelke
, et al.
·
Cancer Research
·
1
Abstract 1804: IND-ready clinical candidate for HPK1 developed with excellent efficacy and safety profile
2022
·
Sravan Mandadi
, Sanjib Das
, et al.
·
Cancer Research
·
1
GRC39815-A novel inhaled ROR?t inhibitor as a potential first in class treatment option for COPD
2021
·
Abhay Kulkarni
, Sanjib Das
, et al.
·
European Respiratory Journal
·
1
Abstract 1709: Novel small molecule HPK1 inhibitor induces immunogenic anti-tumor effects
2021
·
Sachin S. Chaudhari
, Malini Bajpai
, et al.
·
Cancer Research
·
1
Assessment of draughtability of bullocks of Orissa in test track and field condition.
2009
·
B. K. Behera
, Dayanidhi Behera
, et al.
·
The Indian Journal of Animal Sciences
·
1
Abstract 3413: Discovery of GRC 65327, a best-in-class, selective and potent Cbl-b inhibitor for the treatment of advanced solid cancers
2025
·
Jiju Mani
, Atul Akarte
, et al.
·
Cancer Research
1025 GRC 65327, a novel small molecule selective Cbl-b inhibitor for solid tumors
2024
·
Sachin Chaudhari
, Vidya Ganapati Kattige
, et al.
·
Journal for ImmunoTherapy of Cancer
441 (PB429): GRC 70267, a novel first-generation small molecule degrader of IRAK-M with anti-tumor activity
2024
·
N. Gowda
, R.S. Senaiar
, et al.
·
European Journal of Cancer
Effect of Saccharolactone on CYP-mediated Metabolism of Xenobiotics
2023
·
Dayanidhi Behera
, Pankaj Jain
, et al.
·
Drug Metabolism and Bioanalysis Letters
848 Novel small molecule HPK1 inhibitor PCC-1 induces strong anti-tumor activity
2021
·
Sanjib Das
, Sravan Mandadi
, et al.
·
Journal for ImmunoTherapy of Cancer
PDF
Show more works
View as search
Works count:
27
Citation count:
135
H-index:
8
I10-index:
5
Year
Topic
Type